SE413505B - Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet - Google Patents

Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet

Info

Publication number
SE413505B
SE413505B SE7513255A SE7513255A SE413505B SE 413505 B SE413505 B SE 413505B SE 7513255 A SE7513255 A SE 7513255A SE 7513255 A SE7513255 A SE 7513255A SE 413505 B SE413505 B SE 413505B
Authority
SE
Sweden
Prior art keywords
amids
procedure
preparation
cyclic amines
pharmaceutical activity
Prior art date
Application number
SE7513255A
Other languages
English (en)
Swedish (sv)
Other versions
SE7513255L (sv
Inventor
F Cassidy
G Wootton
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7513255L publication Critical patent/SE7513255L/xx
Publication of SE413505B publication Critical patent/SE413505B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
SE7513255A 1974-11-29 1975-11-25 Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet SE413505B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51733/74A GB1524818A (en) 1974-11-29 1974-11-29 12-azaprostaglandins

Publications (2)

Publication Number Publication Date
SE7513255L SE7513255L (sv) 1976-05-31
SE413505B true SE413505B (sv) 1980-06-02

Family

ID=10461163

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7513255A SE413505B (sv) 1974-11-29 1975-11-25 Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet
SE7809907A SE7809907L (sv) 1974-11-29 1978-09-20 Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7809907A SE7809907L (sv) 1974-11-29 1978-09-20 Mellanprodukter for anvendnig vid framstellning av farmaceutiskt anvendbara foreningar

Country Status (19)

Country Link
US (1) US4299970A (xx)
JP (1) JPS51125278A (xx)
AT (1) AT359216B (xx)
AU (2) AU496753B2 (xx)
BE (1) BE835989A (xx)
CA (1) CA1088062A (xx)
CH (2) CH626325A5 (xx)
DE (1) DE2552312A1 (xx)
DK (1) DK539775A (xx)
ES (1) ES443081A1 (xx)
FI (1) FI753341A (xx)
FR (2) FR2313043A1 (xx)
GB (1) GB1524818A (xx)
HU (2) HU176752B (xx)
IE (1) IE41877B1 (xx)
NL (1) NL7513903A (xx)
NO (2) NO753935L (xx)
SE (2) SE413505B (xx)
ZA (1) ZA757121B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362839A1 (fr) * 1976-06-03 1978-03-24 Wellcome Found Derives de l'hydantoine et medicaments contenant ces substances
IL53559A0 (en) 1976-12-18 1978-03-10 Beecham Group Ltd Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them
EP0007180B1 (en) * 1978-06-15 1983-03-30 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
AU4806879A (en) * 1978-06-15 1979-12-20 Beecham Group Limited 1,2,4 triazole derivatives
IL58384A0 (en) * 1978-10-14 1980-01-31 Beecham Group Ltd 12-aza analogues of prostcyclin their preparation and pharmaceutical composition containing them
US6211226B1 (en) * 1998-12-17 2001-04-03 Alcon Laboratories, Inc. 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
WO2003103604A2 (en) * 2002-06-01 2003-12-18 Applied Research Systems Ars Holding N.V Gamma lactams as prostaglandin agonists and use thereof
US7053085B2 (en) * 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7696243B2 (en) * 2004-12-06 2010-04-13 Merck Serono, S.A. Pyrrolidin-2-one derivatives for use as DP1 receptor agonists
WO2023212495A1 (en) * 2022-04-29 2023-11-02 Zymergen Inc. Novel bio-based compound, method of forming the compound, and adhesive compositions containing the novel compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2343769A (en) * 1941-09-27 1944-03-07 Du Pont Aliphatic aminoacyl compound and method for preparing same
US2582257A (en) * 1950-09-15 1952-01-15 Parke Davis & Co Esters and methods for obtaining the same
NZ182263A (en) * 1975-10-25 1979-01-11 Beecham Group Ltd 2-carboxyalkyl-4,4-dimethyl-1-hydroxy-alkyl-pyrrolidin-3,5-dione derivativesand pharmaceutical compositions
NZ182264A (en) * 1975-10-25 1979-01-11 Beecham Group Ltd 2-carboxyalkyl-1-hydroxyalkyl-pyrrolidin-3,5-dione or-piperidin-3,6-dione derivatives prarmaceutical compostions
US4201864A (en) * 1975-10-25 1980-05-06 Beecham Group Limited Oxy-alkylamino acids and esters

Also Published As

Publication number Publication date
GB1524818A (en) 1978-09-13
FR2379510A1 (fr) 1978-09-01
DK539775A (da) 1976-05-30
ATA898375A (de) 1980-03-15
AU8710775A (en) 1977-06-02
HU174537B (hu) 1980-02-28
AU3942778A (en) 1980-03-06
ZA757121B (en) 1976-10-27
SE7513255L (sv) 1976-05-31
HU176752B (en) 1981-05-28
US4299970A (en) 1981-11-10
IE41877L (en) 1976-05-29
ES443081A1 (es) 1977-05-01
IE41877B1 (en) 1980-04-09
JPS51125278A (en) 1976-11-01
FI753341A (xx) 1976-05-30
CA1088062A (en) 1980-10-21
NO753935L (xx) 1976-06-01
FR2313043A1 (fr) 1976-12-31
BE835989A (fr) 1976-05-26
FR2379510B1 (xx) 1982-10-29
AU496753B2 (en) 1978-10-26
NO783765L (no) 1976-06-01
FR2313043B1 (xx) 1982-08-13
NL7513903A (nl) 1976-06-01
CH626325A5 (xx) 1981-11-13
AT359216B (de) 1980-10-27
SE7809907L (sv) 1978-09-20
CH629748A5 (de) 1982-05-14
AU526356B2 (en) 1983-01-06
DE2552312A1 (de) 1976-08-12

Similar Documents

Publication Publication Date Title
SE7802176L (sv) Tertiera cykliska aminer och forfarande for deras framstellning
SE411517B (sv) Inhalator for administration av pulverformiga substanser
SE428426B (sv) Anordning for inandning av lekemedel i pulverform
FR2276832A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
SE425659B (sv) Forfarande for framstellning av tripeptider med antidpressiva och tyroidhormonfrigoringsstimulerande egenskaper
SE413505B (sv) Forfarande for framstellning av cykliska aminer och amider med farmaceutisk aktivitet
SE7511932L (sv) Aralifatiska kveveforeningar och forfarande for framstellning derav
NO141472C (no) Fremgangsmaate for fremstilling av polysakkarider og derivater derav
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
SE7508649L (sv) Forfarande och anordning for undersokning av vetskor
SE7513606L (sv) Derivat av tetanustoxineta forfarande for deras framstellning och medel innehallande desamma
NO144773C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive aminer.
MX3499E (es) Procedimiento para preparar derivados de organofosforotiolatos y fosforoditiolatos
SE7607741L (sv) Forfarande for framstellning av aminer och nya mellanprodukter for detta
SE431204B (sv) Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav
SE410596B (sv) Analogiforfarande for framstellning av bensoyl-fenylalanyl-tyrosinderivat med terapeutisk verkan
SE7513136L (sv) Heterocykliska foreningar och forfarande for framstellning derav
SE407150B (sv) Injektionsspruta och forfarande for framstellning av densamma
SE398230B (sv) Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan
BE824827A (fr) Derives du pipane et leur preparation
SE7506588L (sv) Forfarande for framstellning av cefalosporiner och mellanprodukter
SE7506406L (sv) Nya cyklopentanderivat och forfarande for deras framstellning
SE7510782L (sv) Forfarande och anordning for framstellning av strengformiga foremal
SE7509584L (sv) Forfarande och anordning for elektristatisk utfellning av partiklar
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan